Literature DB >> 12108819

Depression, anxiety, and the gastrointestinal system.

E A Mayer1, M Craske, B D Naliboff.   

Abstract

Functional disorders of the digestive system, such as irritable bowel syndrome, are often associated with affective disorders, such as depression, anxiety, panic, and posttraumatic stress disorder (PTSD). Some of these associations are observed not only in clinical populations, but also in population-based samples, suggesting a relationship with pathophysiologic mechanisms underlying both gastrointestinal (GI) dysfunction and certain affective disorders. Sustained and acute life-threatening stressors play an important role in the onset and modulation of GI symptoms as well as in the development of affective disorders and PTSD. A neurobiological model is proposed that attempts to explain the development of visceral hypersensitivity, the neuroendocrine and autonomic dysfunction characteristic of functional GI disorders, as well as the overlap with affective disorders.

Entities:  

Mesh:

Year:  2001        PMID: 12108819

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  67 in total

Review 1.  Fibromyalgia: a rheumatologic diagnosis?

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

Review 2.  Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology.

Authors:  Lisa E Goehler; Mark Lyte; Ronald P A Gaykema
Journal:  Brain Behav Immun       Date:  2007-04-10       Impact factor: 7.217

3.  Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Bruce D Naliboff; Steve M Berman; Brandall Suyenobu; Eduardo P Vianna; Kirsten Tillisch; Emeran A Mayer
Journal:  Neuroimage       Date:  2009-06-06       Impact factor: 6.556

Review 4.  Clinical practice. Irritable bowel syndrome.

Authors:  Emeran A Mayer
Journal:  N Engl J Med       Date:  2008-04-17       Impact factor: 91.245

5.  Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome.

Authors:  Kate Wolitzky-Taylor; Michelle G Craske; Jennifer S Labus; Emeran A Mayer; Bruce D Naliboff
Journal:  Behav Res Ther       Date:  2012-06-23

6.  A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity.

Authors:  Richard J Traub; Dong-Yuan Cao; Jane Karpowicz; Sangeeta Pandya; Yaping Ji; Susan G Dorsey; Dean Dessem
Journal:  J Pain       Date:  2014-06-26       Impact factor: 5.820

7.  Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis.

Authors:  J S Labus; B N Naliboff; J Fallon; S M Berman; B Suyenobu; J A Bueller; M Mandelkern; E A Mayer
Journal:  Neuroimage       Date:  2008-03-20       Impact factor: 6.556

8.  Effects of fluoxetine on mast cell morphology and protease-1 expression in gastric antrum in a rat model of depression.

Authors:  Zhen-Hua Chen; Ling Xiao; Ji-Hong Chen; He-Shen Luo; Gao-Hua Wang; Yong-Lan Huang; Xiao-Ping Wang
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

9.  The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.

Authors:  Pontus Karling; Åke Danielsson; Mikael Wikgren; Ingegerd Söderström; Jurgen Del-Favero; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

10.  Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat.

Authors:  Christian Twiss; Lisa Kilpatrick; Michelle Craske; C A Tony Buffington; Edward Ornitz; Larissa V Rodríguez; Emeran A Mayer; Bruce D Naliboff
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.